Does OrganiGram’s (OGI) New Equity Program Mean it’s Time to Buy the Stock?

: ogi | Organigram Holdings Inc. News, Ratings, and Charts

ogi – This week, OrganiGram Holdings Inc. (OGI) announced it had established an At-The-Market equity program allowing the company to issue up to C$55,000,000 of common shares from its treasury to the public.

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

This week, OrganiGram Holdings Inc. (OGI) announced it had established an At-The-Market equity program allowing the company to issue up to C$55,000,000 of common shares from its treasury to the public (on occasion, at the company’s discretion).

Shares sold via the ATM Program will be sold through the NASDAQ, the Toronto Stock Exchange (the “TSX”), and any other market where Common Shares are listed, quoted or traded, at the market price during the time of transaction. 

Organigram will determine the volume and timing of distributions under the ATM Program – if any. The company plans to use any net proceeds from the ATM Program to finance capital projects, for general corporate purposes, and to pay down debts.

OGI’s ATM Program will either be in effect until December 25, 2021, or until all Common Shares are issued and sold pursuant to the ATM Program (unless terminated sooner by OrganiGram Holdings Inc. or its agents. The “agents” are collectively referred to as Canadian agent BMO Nesbitt Burns Inc., and U.S. agent BMO Capital Markets Corp.

Could the ATM program be in response to a lukewarm earnings report?

Just last week OGI released its Q4 and fiscal year-end report — and the results were less than stellar.

The company posted a bottom-line loss in the last quarter totaling C$22.5 million. The consensus estimate had pointed to a loss of 1 cent per share, which became a concern as it followed a profit of C$18.2 million (or 12 cents per share), when compared to the year-over-year quarter. 

In response to the company’s disappointing performance, OGI executives partly pointed to a lackluster retail network and slower-than-expected store openings throughout Ontario. 

“Quarter to quarter revenue is expected to continue to be volatile due to the timing of large pipeline orders for Ontario, in particular, where there is a centralized distribution model and where store additions are difficult to forecast,” the company said in a statement. 

Nonetheless, a lot of investors have maintained their bullishness on this stock. OrganiGram is renowned for its operational efficiencies, operating out of a single facility located in New Brunswick, making it more efficient than some of its peers.

The company has placed a significant focus on producing premium-grade marijuana, versus racing to open giant new facilities across the globe. Additionally, OGI has received licensing approval for 17 new grow rooms, which should increase production capacity to 76,000 kilograms per year.

Corey Hammill, a Paradigm analyst, believes that this positions the company to win. He also thinks that OrganiGram will benefit from Cannabis 2.0 (when edibles and derivatives become legal for recreational use in Canada). Thus, he doubled down his “buy” rating and $3.95 price target.

According to a consensus breakdown, six buys and three holds add up to a “moderate buy.” The $6 average price target indicates upside potential of 136%. 

During its most recent earnings call, OrganiGram stated that it expects to generate a higher net revenue in the upcoming Q1 than it did in the previous Q4, based on increased sales to provinces and higher wholesale revenue.

The company also highlighted the 70% completion of its Moncton Campus facility expansion, during the previous quarter.

 


OGI shares were trading at $2.59 per share on Friday afternoon, down $0.03 (-1.15%). Year-to-date, OGI has declined -27.41%, versus a 27.88% rise in the benchmark S&P 500 index during the same period.


About the Author: Eric Bowler


Eric is an accomplished journalist providing in-depth insights for more than two decades, with a special focus on the cannabis industry. Learn more about Eric’s background, along with links to his most recent articles. More...


More Resources for the Stocks in this Article

TickerPOWR RatingIndustry RankRank in Industry
OGIGet RatingGet RatingGet Rating
CGCGet RatingGet RatingGet Rating
ACBGet RatingGet RatingGet Rating
CRONGet RatingGet RatingGet Rating
APHAGet RatingGet RatingGet Rating
TLRYGet RatingGet RatingGet Rating
CTSTGet RatingGet RatingGet Rating
MJGet RatingGet RatingGet Rating

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Top Stories on StockNews.com

NYSE: SPY | SPDR S&P 500 News, Ratings, and Charts

1 Equation Keeps the Bear Market in Hibernation

We just endured our first negative week for stocks (SPY) in quite a while. This article will center your attention on what is truly important to keep riding the bull to new heights this year.
NYSE: SPY | SPDR S&P 500 News, Ratings, and Charts

The Economy Keeps Weakening: 2 Critical Things Investors Need to Know

Today's featured article covers 2 critical tips that investors need to know in light of the weakening economy. Will stocks continue to grow in 2020? Continue reading for more details.
NASDAQ: FB | Facebook, Inc. -  News, Ratings, and Charts

2 Tech Stocks To Consider Buying On Dips

Facebook and Salesforce.com emerged from massive breakouts in late 2019, and are both expecting to see strong earnings growth in FY-2020.
NYSE: IIPR | Innovative Industrial Properties, Inc.  News, Ratings, and Charts

Will Shares of Innovative Industrial Properties (IIPR) Continue Rising in 2020?

Despite the harsh bear market in the cannabis industry in 2019, Innovative Industrial Properties (IIPR) still managed to come out on top.
NYSE: SPY | SPDR S&P 500 News, Ratings, and Charts

When Will This Bull Rally Tire Out?

Typically a stock rally will end when you least expect it. But when you look at the current tea leaves, it does seem like conditions are right for at least a consolidation period. Get the full story below...

Read More Stories


More Organigram Holdings Inc. (ogi) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All ogi News
Page generated in 1.6018 seconds.